Roche (RHHVF) Stock Price, News & Analysis

Company Overview

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Key Stats

• Today's Range: $338.80 to $345.75
• 50-Day Range: $282.00 to $347.10
• 52-Week Range: $233.12 to $351.40
• Volume: 1,537 shs
• Average Volume: 4,580 shs
• Market Capitalization: N/A
• P/E Ratio: 31.62
• Dividend Yield: 2.28%
• Price Target: N/A
• Consensus Rating: N/A

Roche Stock Analysis - MarketRank™

Roche scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Roche.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Roche is 31.62, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.42.

Price to Earnings Ratio vs. Sector

The P/E ratio of Roche is 31.62, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 23.65.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Roche has a short interest ratio ("days to cover") of 195.8, which indicates bearish sentiment.

Change versus previous month

Short interest in Roche has recently increased by 8.28%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Roche pays a meaningful dividend of 3.21%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Roche does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Roche is 72.16%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Roche has a short interest ratio ("days to cover") of 195.8, which indicates bearish sentiment.

Change versus previous month

Short interest in Roche has recently increased by 8.28%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 0.07

News Sentiment

Roche has a news sentiment score of 0.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.72 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Roche this week, compared to 1 article on an average week.

Search Interest

1 people have searched for RHHVF on MarketBeat in the last 30 days.

MarketBeat Follows

1 people have added Roche to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Roche insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 29.01% of the stock of Roche is held by institutions.

RHHVF Stock Analysis - Frequently Asked Questions

How have RHHVF shares performed this year?

Roche's stock was trading at $280.00 on January 1st, 2025. Since then, RHHVF shares have increased by 22.1% and is now trading at $341.7880.
View the best growth stocks for 2025 here.

How do I buy shares of Roche?

Shares of RHHVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - General
• Sub-Industry: Personal Services
• Current Symbol: OTCMKTS:RHHVF
• CIK: N/A
• Web: www.roche.com
• Phone: (161) 688-1111
• Fax: N/A
• Employees: 103,605
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 31.62
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A